Gss Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Gss Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [1]
The GSS gene (Glutathione Synthetase) encodes the enzyme glutathione synthetase, which catalyzes the second step of glutathione biosynthesis. Glutathione is the body's most important antioxidant, and GSS deficiency leads to severe metabolic disorders and neurodegeneration. [2]
| Attribute | Value | [3]
|-----------|-------| [4]
| Gene Symbol | GSS |
| Full Name | Glutathione Synthetase |
| Chromosomal Location | 20q11.22 |
| NCBI Gene ID | 2937 |
| OMIM ID | 601002 |
| Ensembl ID | ENSG00000100977 |
| UniProt ID | P16455 |
Glutathione synthetase (GS) is a key enzyme in glutathione biosynthesis:
GSS is expressed in all brain cell types:
| Compound | Mechanism | Status |
|---|---|---|
| N-acetylcysteine | GSH precursor | Clinical trials |
| Glutathione (reduced) | Direct supplementation | Research |
| Sulforaphane | Nrf2 activation → ↑ GSS | Research |
Gss Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Gss Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Glutathione synthetase (GSS) catalyzes the second step of glutathione biosynthesis:
GSS supports antioxidant defense:
| Approach | Status | Notes |
|---|---|---|
| N-acetylcysteine | Clinical | Glutathione precursor |
| GSS expression enhancement | Research | Gene therapy |
| Small molecule activators | Preclinical | Enzyme activation |
Ristoff M, et al. (2000). Glutathione synthetase deficiency. Ristoff M, et al. 2000. ↩︎
Townsend DM, et al. (2003). The importance of glutathione in human disease. Townsend DM, et al. 2003. ↩︎
Dringen R, et al. (1999). Glutathione in neurons and glial cells. Dringen R, et al. 1999. ↩︎
Sian J, et al. (1994). Alterations in glutathione levels in Parkinson's disease. Sian J, et al. 1994. ↩︎